Literature DB >> 24878057

Von hippel-lindau disease associated pulmonary carcinoid with cranial metastasis.

Chao Zhang1, Andrew I Yang, Lucas Vasconcelos, Seog Moon, Chunzhang Yang, Cody L Nesvick, Lola Saidkhodjaeva, Ziedulla Abdullaev, Svetlana D Pack, Arunima Ghosh, Prashant Chittiboina, John D Heiss, Zhengping Zhuang, Martha M Quezado, Kareem A Zaghloul.   

Abstract

CONTEXT: Carcinoids have rarely been described in von Hippel-Lindau (VHL) disease.
OBJECTIVE: We describe the first reported case of a patient with VHL who developed a pulmonary carcinoid that subsequently metastasized to a pre-existent cranial hemangioblastoma.
RESULTS: Histological and immunohistochemical features of the metastatic lesion were similar to the primary carcinoid. Both lesions demonstrated heterozygous VHL gene deletions with fluorescence in situ hybridization analysis.
CONCLUSIONS: This case provides direct molecular genetic evidence of an association between VHL and carcinoids.

Entities:  

Mesh:

Year:  2014        PMID: 24878057      PMCID: PMC4121022          DOI: 10.1210/jc.2014-1732

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  20 in total

1.  Metastasis of clear-cell renal carcinoma to cerebellar hemangioblastoma in von Hippel Lindau disease: rare or not investigated?

Authors:  C Mottolese; H Stan; F Giordano; D Frappaz; D Alexei; N Streichenberger
Journal:  Acta Neurochir (Wien)       Date:  2001-10       Impact factor: 2.216

2.  Clear cell carcinoid tumor of the gallbladder: another distinctive manifestation of von Hippel-Lindau disease.

Authors:  P A Sinkre; L Murakata; L Rabin; M P Hoang; J Albores-Saavedra
Journal:  Am J Surg Pathol       Date:  2001-10       Impact factor: 6.394

3.  Identification of the von Hippel-Lindau disease tumor suppressor gene.

Authors:  F Latif; K Tory; J Gnarra; M Yao; F M Duh; M L Orcutt; T Stackhouse; I Kuzmin; W Modi; L Geil
Journal:  Science       Date:  1993-05-28       Impact factor: 47.728

4.  Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function.

Authors:  C E Stebbins; W G Kaelin; N P Pavletich
Journal:  Science       Date:  1999-04-16       Impact factor: 47.728

5.  Von Hippel-Lindau disease: a genetic study.

Authors:  E R Maher; L Iselius; J R Yates; M Littler; C Benjamin; R Harris; J Sampson; A Williams; M A Ferguson-Smith; N Morton
Journal:  J Med Genet       Date:  1991-07       Impact factor: 6.318

6.  Brain carcinoid metastases: outcomes and prognostic factors.

Authors:  Grant W Mallory; Shanna Fang; Caterina Giannini; Jamie J Van Gompel; Ian F Parney
Journal:  J Neurosurg       Date:  2013-02-08       Impact factor: 5.115

Review 7.  von Hippel-Lindau disease.

Authors:  Russell R Lonser; Gladys M Glenn; McClellan Walther; Emily Y Chew; Steven K Libutti; W Marston Linehan; Edward H Oldfield
Journal:  Lancet       Date:  2003-06-14       Impact factor: 79.321

8.  Renal cell cancer: best recipient of tumor-to-tumor metastasis.

Authors:  A Sella; J Y Ro
Journal:  Urology       Date:  1987-07       Impact factor: 2.649

9.  [Malignant carcinoid and phaeochromocytoma in von-Hippel-Lindau's disease--a case report (author's transl)].

Authors:  A Kees
Journal:  Wien Klin Wochenschr       Date:  1980-03-14       Impact factor: 1.704

10.  Carcinoid tumour of the common bile duct--a novel complication of von Hippel-Lindau syndrome.

Authors:  I W Fellows; I H Leach; P G Smith; P J Toghill; J Doran
Journal:  Gut       Date:  1990-06       Impact factor: 23.059

View more
  2 in total

1.  Pulmonary mucosa-associated lymphoma in a patient with von Hippel-Lindau disease.

Authors:  David M Straughan; Sid Kerkar; Saїd C Azoury; Emily S Reardon; David S Schrump
Journal:  J Surg Case Rep       Date:  2015-07-14

2.  Identification of a VHL gene mutation in atypical Von Hippel-Lindau syndrome: genotype-phenotype correlation and gene therapy perspective.

Authors:  Dali Tong; Yao Zhang; Jun Jiang; Gang Bi
Journal:  Cancer Cell Int       Date:  2021-12-19       Impact factor: 5.722

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.